Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Teplizumab> ?p ?o }
Showing triples 1 to 67 of
67
with 100 triples per page.
- Teplizumab abstract "Teplizumab (also known as MGA031 and hOKT3γ1(Ala-Ala)) is a humanized monoclonal antibody that is used as an immunosuppressive drug. The Fc region of this antibody has been engineered to have Fc receptor non-binding (FNB) properties. Teplizumab was originally developed at Columbia University, and was then further developed at MacroGenics, Inc.This antibody has been used in clinical trials with the aim of protecting the remaining β-cells in newly diagnosed type 1 diabetes mellitus patients, but "these agents [i. e. anti-CD3-antibodies] alone do not restore normal glucose control".Eli Lilly licensed the drug back in 2007 from MacroGenics with a $41 million upfront and a billion dollars pledged for milestones.It is in Phase-3 clinical trials for Type-1 DM. One-year data from one phase III trial was disappointing.".
- Teplizumab atcPrefix "none".
- Teplizumab casNumber "876387-05-2".
- Teplizumab fdaUniiCode "S4M959U2IJ".
- Teplizumab wikiPageExternalLink autoimmunity.mspx.
- Teplizumab wikiPageExternalLink rebooting-body.
- Teplizumab wikiPageID "12149047".
- Teplizumab wikiPageLength "4288".
- Teplizumab wikiPageOutDegree "12".
- Teplizumab wikiPageRevisionID "622291026".
- Teplizumab wikiPageWikiLink Anti-CD3_monoclonal_antibody.
- Teplizumab wikiPageWikiLink Beta_cell.
- Teplizumab wikiPageWikiLink CD3_(immunology).
- Teplizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Teplizumab wikiPageWikiLink Diabetes_mellitus_type_1.
- Teplizumab wikiPageWikiLink Eli_Lilly_and_Company.
- Teplizumab wikiPageWikiLink Fc_receptor.
- Teplizumab wikiPageWikiLink Fc_region.
- Teplizumab wikiPageWikiLink Fragment_crystallizable_region.
- Teplizumab wikiPageWikiLink Immunosuppressive_drug.
- Teplizumab wikiPageWikiLink Monoclonal_antibody.
- Teplizumab wikiPageWikiLink Popular_Science.
- Teplizumab wikiPageWikiLink Type_1_diabetes_mellitus.
- Teplizumab wikiPageWikiLinkText "Teplizumab".
- Teplizumab wikiPageWikiLinkText "teplizumab".
- Teplizumab atcPrefix "none".
- Teplizumab c "6462".
- Teplizumab casNumber "876387".
- Teplizumab chemspiderid "NA".
- Teplizumab h "9938".
- Teplizumab hasPhotoCollection Teplizumab.
- Teplizumab mabType "mab".
- Teplizumab molecularWeight "145.8".
- Teplizumab n "1738".
- Teplizumab o "2022".
- Teplizumab s "46".
- Teplizumab source "zu/o".
- Teplizumab target CD3_(immunology).
- Teplizumab type "mab".
- Teplizumab unii "S4M959U2IJ".
- Teplizumab verifiedfields "changed".
- Teplizumab verifiedrevid "470602069".
- Teplizumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Teplizumab wikiPageUsesTemplate Template:Drugbox.
- Teplizumab wikiPageUsesTemplate Template:Immunosuppressants.
- Teplizumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Teplizumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Teplizumab wikiPageUsesTemplate Template:Reflist.
- Teplizumab subject Category:Monoclonal_antibodies.
- Teplizumab hypernym Antibody.
- Teplizumab type Article.
- Teplizumab type ChemicalSubstance.
- Teplizumab type Drug.
- Teplizumab type Antibody.
- Teplizumab type Article.
- Teplizumab type Chemical.
- Teplizumab type Drug.
- Teplizumab type ChemicalObject.
- Teplizumab type Thing.
- Teplizumab type Q8386.
- Teplizumab comment "Teplizumab (also known as MGA031 and hOKT3γ1(Ala-Ala)) is a humanized monoclonal antibody that is used as an immunosuppressive drug. The Fc region of this antibody has been engineered to have Fc receptor non-binding (FNB) properties.".
- Teplizumab label "Teplizumab".
- Teplizumab sameAs m.02vrctm.
- Teplizumab sameAs Q7701358.
- Teplizumab sameAs Q7701358.
- Teplizumab wasDerivedFrom Teplizumab?oldid=622291026.
- Teplizumab isPrimaryTopicOf Teplizumab.